Vaccine-Antibodies

Name: Vaccine-Antibodies
Creator: Campos Aguilar, Myriam
Published: 2025-03-31T00:00:00+08:00

Figshare2025-03-31 更新2026-04-08 收录

疫苗免疫原性

T细胞免疫应答

数据链接：

https://figshare.com/articles/dataset/Vaccine-Antibodies/28700588/1 数据链接链接失效反馈

官方服务：

资源简介：

Data to Comparison of Antibody, T Cell, and NK Cell Responses Induced by mRNA, Adenoviral Vector, and Inactivated Virus Vaccines in SARS-CoV-2 Naïve Individuals

提供机构：

Campos Aguilar, Myriam

创建时间：

2025-03-31

Tissue-resident Memory and Circulating T cells are Early Responders to Pre-surgical Cancer Immunotherapy. Tissue-resident Memory and Circulating T cells are Early Responders to Pre-surgical Cancer Immunotherapy

癌症免疫治疗

T细胞免疫应答

Pre-surgical (neoadjuvant) immune checkpoint blockade has shown promising activity in multiple cancer types, but the molecular mechanisms are not well understood. Here, we characterized early kinetic

NIAID Data Ecosystem70

CD4 + T cell proliferation following incubation of PBMCs ex vivo with different antigens.

T细胞免疫应答

抗原特异性

CD4+ T cell proliferation following incubation of PBMCs ex vivo with different antigens.

NIAID Data Ecosystem40

Safety and immunogenicity of SW-BIC-213, a modified COVID-19 Lipo-Polyplex mRNA vaccine, in Laotian healthy adults aged 18 years and above: a Phase 1/2 trial

COVID-19mRNA疫苗临床试验

疫苗免疫原性

Safety and immunogenicity of SW-BIC-213, a modified COVID-19 Lipo-Polyplex mRNA vaccine, in Laotian healthy adults aged 18 years and above: a Phase 1/2 trial

NCATS Open Data2023-10-12 更新00

Cryo-EM structure of the Sars-Cov2 S trimer without RBDs

病毒蛋白结构解析

疫苗免疫原性

Cryo-EM structure of the Sars-Cov2 S trimer without RBDs Descriptor: Spike glycoprotein,Fibritin Authors: Effantin, G. Deposit date: 2023-11-28 Release date: 2024-12-11 Last modified: 2025-07-02 Metho

Protein Data Bank Japan2025-07-02 更新40

Interim Analysis of a Phase I Randomized Clinical Trial on the Safety and Immunogenicity of the mRNA-1283 SARS-CoV-2 Vaccine in Adults

新冠疫苗I期临床试验

疫苗免疫原性

Interim Analysis of a Phase I Randomized Clinical Trial on the Safety and Immunogenicity of the mRNA-1283 SARS-CoV-2 Vaccine in Adults

NCATS Open Data2022-11-08 更新00